Yonsei Institute
for Global Health

Severance International Fellowship (SIF) is open to foreign physicians, dentists, nurses, medical technicians, or hospital administrators who wish to experience clinical care, operative procedures, and participate in research activities at Severance Hospital(Sinchon) Seoul, Korea. This program builds on the hospital’s long legacy and mission to educate future clinical leaders in healthcare and ultimately reducing health inequalities in the global society.

1. All foreign trainees have to be eligible to enter Korea without violating Article 11(Prohibition, etc. of Entry) of the Immigration Act of the Republic of Korea.
   
   
2. All foreign trainees have to be enough fluent in English or Korean to participate in the training. Trainees have to be not only able to do daily conversation, but also have to understand and be able to listen, read, write, and speak about their professional specialty area in English or Korean. Severance Academy might request official proof of the trainee's language proficiency if necessary. Interpretations are NOT available.
   
   
3. All foreign trainees have to be registered as trainees in Severance Academy, mainly by applying online at this homepage. (Email applications are not recommended.)
   
   
4. All foreign trainees have to submit a immunization form that asks for proof of vaccination or antibody test results for specific diseases designated by Severance Hospital. Please download the form here.

The Vitreoretina fellowship offers opportunities of outpatient observations and surgery observations including Trans pars plana vitrectomy (Membranectomy, ILM peel, Endolaser, tamponade, etc.) Scleral encircling, Scleral buckling, Cryopexy, Laser indirect ophthalmoscopy, 

Intravitreal injection, Panretinal photocoagulation, Photodynamic therapy, Ocular tumor surgery (Sclerouvectomy, Brachytherapy, Transpupillary thermotherapy, etc.) and the weekly Retina meeting. 

If willing to, international fellows may also participate in the basic lab meetings and the laboratory doing research on Molecular diagnosis of intraocular tumors such as Uveal melanoma, Retinoblastoma, and Lymphoma, research on the mechanism of resistance to therapeutic drugs, research on retinal disease models and new drugs using retinal organoids, gene therapy for macular degeneration.